Webinar: Vaccine Confidence
December 18, 11:30am-4PM EDT
Register here for this event
Join the National Academies of Sciences, Engineering, and Medicine for a discussion of promising strategies from the behavioral and social sciences to help promote the uptake of vaccines to prevent COVID-19.
To inform a forthcoming rapid expert consultation on building public confidence in SARS-CoV-2 vaccines, the Societal Experts Action Network (SEAN) of the National Academies will hold an information gathering session on vaccine confidence. The session will cover the current state of vaccine confidence, reasons for hesitancy, and best practices for messaging. Facilitated discussions will incorporate special attention to communities at higher risk of contracting and dying from COVID-19, including underserved and vulnerable communities. Drawing from what is known about reaching and engaging diverse audiences to change beliefs and attitudes, this session will illustrate strategies that are likely to promote uptake of FDA-approved vaccines to prevent COVID-19.
This project is in collaboration with the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats
What Clinicians Need to Know About the Pfizer-BioNTech and Moderna COVID-19 Vaccines
Join CDC for an overview of the Pfizer-BioNTech and Moderna COVID-19 vaccines. Clinicians will learn about:
- vaccine characteristics and administration
- vaccinating special populations
Participants will also get answers to a number of clinical questions CDC received about these new vaccines.
Webinar: COVID-19 Response Vaccine Update
December 21, 3-4PM EDT
Register in advance for this webinar: COVID-19 Response Vaccine Update
Please join the CDC for their weekly partner call for updates on the COVID-19 response, including new resources for the private sector and the general public.
- Dr. Nancy Messonnier, Director of the National Center for Immunization and Respiratory Diseases and Lead for the CDC COVID-19 Vaccine Task Force
- Dr. Sarah Mbaeyi, Medical Officer, National Center for Immunization and Respiratory Diseases and Lead for the Clinical Guidelines Team, Vaccine Task Force
- Ms. Michelle Putnam, Deputy for Partnerships and Risk Management, CDC COVID-19 Emergency Response (Moderator)
Dr. Nancy Messonnier, Director of the National Center for Immunization and Respiratory Diseases and Lead for the CDC COVID-19 Vaccine Task Force will provide updates on the current status of COVID-19 vaccines. Dr. Sarah Mbaeyi, Medical Officer with the National Center for Immunization and Respiratory Diseases and Lead for the CDC COVID-19 Vaccine Task Force’s Clinical Guidelines Team will discuss clinical considerations. Michelle Putnam, Deputy for Partnerships and Risk Management, CDC COVID-19 Emergency Response, for the Partnership Strategy Unit will moderate.
The call will be recorded and posted with previous Partner Update webinars here.
Seqirus-sponsored Ongoing Continuing Medical Education (CME)
Views on the Flu: Maximizing Vaccine Opportunities in the Covid-19 Era
Seqirus has sponsored a Continuing Medical Education (CME) program entitled “Views on the Flu: Maximizing Vaccine Opportunities in the Covid-19 Era. This CME program is an Independent Medscape Educational Webinar and is now available for physician registration at https://www.medscape.org/viewarticle/937531.
The presenters, Kenneth Alexander, MD, PhD and Rachel Caskey, MD, MAPP identify and discuss effective strategies to maximize influenza vaccination in clinical practice during the COVID-19 pandemic and to improve clinicians’ knowledge as it relates to influenza vaccination.
The webinar will be active until September 18, 2021 and is accredited for 0.5 AMA PRA Category 1 Credit™, 0.5 ABIM MOC points, 0.5 ANCC 0.5 ANCC contact hour, and 0.50 Interprofessional Continuing Education (IPCE) credit.
We will continue to share resources to help support customer education as we collectively work to support the CDC’s vaccination goals this season.
CDC’s Clinician and Outreach Communication Activity
What Every Clinician Should Know About COVID-19 Vaccine Safety
To view a recording this presentation, or to see the slides from this presentation, click here to visit the CDC’s COCA website.
CDC’s Clinician Outreach and Communication Activity (COCA) provides timely, accurate, and credible information to clinicians related to emergency preparedness and response and emerging public health threats. On Monday, December 14, 2020, from 1:00-2:00 p.m. ET, COCA presented, “What Every Clinician Should Know about COVID-19 Vaccine Safety.”
During this COCA call, clinicians learned how they can educate their patients about what to expect after COVID-19 vaccination. In addition, they learned how they can play an important role in monitoring the safety of COVID-19 vaccines. This includes encouraging patients to enroll in v-safe, a new smartphone-based, after-vaccination health checked for people who receive COVID-19 vaccines, and to use v-safe to report how they are feeling. Clinicians also learned how to report adverse events (possible side effects) to the Vaccine Adverse Event Reporting System (VAERS).
CDC’s Immunization Resources
CDC has added many more ready-to-use materials to its COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians
CDC has released ready-to-use materials to help build confidence about COVID-19 vaccination. CDC’s COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians.
CDC’s V-Safe Information
CDC launched the V-Safe website with information to encourage vaccinee enrollment in new post-vaccination health-monitoring program.
CDC has also launched website for V-Safe, its new smartphone-based tool that uses text messaging and web surveys so that vaccine recipients can tell CDC if they have any symptoms after getting the COVID-19 vaccine. Based on their responses, CDC may call to get more information. V-Safe also will remind them to get any needed second COVID-19 vaccine dose.
CDC encourages COVID-19 vaccination teams to give recipients a V-Safe information sheet at the time of vaccination. Recipients are encouraged to enroll and complete the surveys when prompted. The information sheet explains V-Safe and provides step-by-step instructions on how to sign up by using their QR code or URL.
Your participation in CDC’s V–Safe will make a difference — it will help us understand COVID-19 vaccines’ safety.
Related Link: CDC’s V-Safe After Vaccination Health Checker